Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(16 sites)
Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Lisbon District Unidade Local De Saude De Santa Maria E.P.E., Lisbon, Lisbon District Spain
INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol., Badalona, Barcelona Hospital Universitari Vall d'Hebron, Barcelona, Barcelona Hospital Clinic de Barcelona, Barcelona, Barcelona Institut Català d'oncologia de L'Hospitalet (ICO-L'Hospitalet), L'Hospitalet de Llobregat, Barcelona Hospital General Universitario Gregorio Marañón, Madrid, Madrid Clínica Universidad Navarra, Madrid, Madrid Hospital Ramon y Cajal, Madrid, Madrid Hospital Universitario 12 de Octubre, Madrid, Madrid Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia Hospital Costa del Sol, Marbella, Málaga Clínica Universidad Navarra, Pamplona, Pamplona Hospital Universitario de Salamanca, Salamanca, Salamanca Hospital Clínico de Valencia, Valencia, Valencia Hospital Universitario y Politécnico La Fe, Valencia, Valencia Age range
18 Years and older
Last updated December 2025